U.S. Online Retail and Ecommerce Stock News

Why Castle Biosciences issued fresh 2025 guidance Castle Biosciences (CSTL) updated its 2025 outlook after issuing new guidance that points to total revenue above US$340 million, supported by higher volumes in its DecisionDx-Melanoma and TissueCypher Barrett’s Esophagus tests. See our latest analysis for Castle Biosciences. Investors appear to be reacting to the stronger 2025 guidance, with a 90 day share price return of 76.29% and a 1 year total shareholder return of 59.76%. However, the 5...

If you are wondering whether Woodward's current share price reflects its true worth, you are not alone. Many investors are asking the same question right now. The stock recently closed at US$327.02, after a 1.8% decline over the last 7 days, a 5.0% gain over 30 days, a 5.2% gain year to date, and a 74.9% gain over the past year. Investors have been watching Woodward closely, as recent company updates and broader sector interest have kept the stock in focus. These developments help frame...

Why First Financial Bancorp is on investors’ radar today First Financial Bancorp (FFBC) is attracting attention after delivering annual revenue of US$815.9 million and net income of US$258.1 million. This has prompted investors to reassess how its current share price lines up with recent fundamentals. See our latest analysis for First Financial Bancorp. Despite a 2.47% one day share price decline to US$26.84, First Financial Bancorp has a 30 day share price return of 4.35% and a 90 day gain...

Some Dream Finders Homes, Inc. ( NYSE:DFH ) shareholders may be a little concerned to see that insider William Lovett...

In recent weeks, analysts have highlighted Amphenol’s upcoming fourth-quarter 2025 earnings release, emphasizing broad-based growth expectations across its Harsh Environment Solutions, Interconnect and Sensor Systems, and Communications Solutions segments. At the same time, Amphenol’s acquisition of CommScope’s Connectivity and Cable Solutions business and its recognition as a growth name in quantitative frameworks have reinforced an image of expanding scale and earnings momentum in key...

If you are wondering whether Procter & Gamble at around US$150 a share is still a solid long term holding or starting to look expensive, the key question is what you are really paying for today. The stock has returned 3.9% over the last 7 days and 3.7% over the last month, while the 1 year return sits at a 6.0% decline compared to gains of 15.3% over 3 years and 32.9% over 5 years. Recent headlines have continued to focus on Procter & Gamble as a global consumer staples heavyweight, with...

Dollar General has agreed to a $15 million class action settlement addressing allegations of deceptive pricing practices. The case centers on claims that checkout prices did not match lower shelf prices advertised in stores. As part of the settlement, the company plans to provide monetary payouts and adopt corrective measures including third party pricing audits and stronger pricing oversight. For investors watching NYSE:DG, this legal development comes with the stock recently closing at...

Earlier this week, Jefferies downgraded Chemed Corporation after highlighting profitability pressures in its Roto-Rooter segment and weaker-than-expected residential plumbing demand in the second quarter. The company also flagged a significant anticipated Medicare Cap revenue limitation for its VITAS hospice subsidiary in Florida for fiscal 2025, raising fresh questions about its healthcare earnings mix. Next, we’ll examine how concerns around Roto-Rooter profitability shape Chemed’s...

Why FormFactor Is Back in Focus for Investors FormFactor (FORM) is in the spotlight after a new Hedgeye short thesis flagged valuation concerns tied to Intel’s guidance cut, while other market commentary highlights rising semiconductor test demand and recent earnings estimate revisions. See our latest analysis for FormFactor. FormFactor’s latest share price of US$73.20 comes after a sharp 9.63% 1-day share price decline and a 6.53% 7-day pullback, which contrast with a 26.08% 1-month and...

During Q4 2025, Riverwater Partners’ Small Cap Strategy initiated a new position in NPK International Inc., citing its role in supplying composite mat solutions for the multi‑year infrastructure buildout underpinning grid expansion and energy system upgrades. The investor highlighted that NPK International’s composite mats, with longer useful life, easier transport and superior cost efficiency versus timber alternatives, place the company at a potential inflection point as it pursues...

Sigma Lithium Corporation ( NASDAQ:SGML ) shareholders will have a reason to smile today, with the analysts making...

Some CAVA Group, Inc. ( NYSE:CAVA ) shareholders may be a little concerned to see that the Co-Founder, Brett Schulman...

Last week saw the newest annual earnings release from Investar Holding Corporation ( NASDAQ:ISTR ), an important...

FS Bancorp, Inc.'s ( NASDAQ:FSBW ) dividend will be increasing from last year's payment of the same period to $0.29 on...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Targa...

Tronox Holdings plc ( NYSE:TROX ) shares have continued their recent momentum with a 47% gain in the last month alone...

Home Federal Bancorp, Inc. of Louisiana's ( NASDAQ:HFBL ) investors are due to receive a payment of $0.135 per share on...

Key Insights Alpha Technology Group's significant insider ownership suggests inherent interests in company's expansion...

Key Insights Given the large stake in the stock by institutions, Eightco Holdings' stock price might be vulnerable to...

Last week saw the newest annual earnings release from BayCom Corp ( NASDAQ:BCML ), an important milestone in the...

Travelers Companies (TRV) is back in focus after reporting fourth quarter earnings that came in well above expectations, while also lifting its share buyback authorization and reaffirming its regular quarterly dividend. See our latest analysis for Travelers Companies. The share price has had a mixed few months, with a 7 day share price return of 3.1%, a 30 day share price return of 4.9%, and a year to date share price return of a 2.6% decline. At the same time, the 1 year total shareholder...

In January 2026, Novavax announced a non-exclusive worldwide License and Option Agreement granting Pfizer access to its Matrix-M adjuvant technology for vaccine development in up to two infectious disease areas, in return for a US$30,000,000 upfront payment and the potential for additional milestones and royalties. The deal effectively shifts development and commercialization responsibilities to Pfizer while positioning Novavax as a specialist supplier of its proprietary adjuvant,...

Heightened attention around Bancorp (TBBK) has built ahead of its upcoming quarterly earnings, with a negative Earnings ESP of 0.69% and growing focus on whether the bank will meet or miss expectations. See our latest analysis for Bancorp. The recent share price moves reflect this tension, with a 1 day share price return of a 5.75% decline and a 90 day share price return of a 14.73% decline, contrasting with a 1 year total shareholder return of 20.93%. This suggests longer term momentum,...

Venture Global (VG) is back in focus after winning an International Chamber of Commerce arbitration against Repsol, a ruling that validated its LNG terminal operations and ordered reimbursement of legal expenses. See our latest analysis for Venture Global. The arbitration win has arrived alongside a sharp swing in market sentiment, with a 1 month share price return of 42.16% and a year to date share price return of 40.34%. However, the 1 year total shareholder return is still down 58.55%,...